Your browser doesn't support javascript.
loading
The Purinergic Receptor P2X4 Promotes Th17 Activation and the Development of Arthritis.
Hamoudi, Chakib; Zhao, Chenqi; Abderrazak, Amna; Salem, Mabrouka; Fortin, Paul R; Sévigny, Jean; Aoudjit, Fawzi.
Afiliación
  • Hamoudi C; Division of Immune and Infectious Diseases, CHU de Québec Research Center, Quebec City, Quebec, Canada.
  • Zhao C; ARThrite Center, Laval University, Quebec City, Quebec, Canada.
  • Abderrazak A; Division of Immune and Infectious Diseases, CHU de Québec Research Center, Quebec City, Quebec, Canada.
  • Salem M; ARThrite Center, Laval University, Quebec City, Quebec, Canada.
  • Fortin PR; Division of Immune and Infectious Diseases, CHU de Québec Research Center, Quebec City, Quebec, Canada.
  • Sévigny J; Division of Immune and Infectious Diseases, CHU de Québec Research Center, Quebec City, Quebec, Canada.
  • Aoudjit F; ARThrite Center, Laval University, Quebec City, Quebec, Canada.
J Immunol ; 208(5): 1115-1127, 2022 03 01.
Article en En | MEDLINE | ID: mdl-35165166

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Experimental / Artritis Reumatoide / Células Th17 / Receptores Purinérgicos P2X4 / Antagonistas del Receptor Purinérgico P2X Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Artritis Experimental / Artritis Reumatoide / Células Th17 / Receptores Purinérgicos P2X4 / Antagonistas del Receptor Purinérgico P2X Tipo de estudio: Prognostic_studies Límite: Animals / Humans / Male Idioma: En Revista: J Immunol Año: 2022 Tipo del documento: Article País de afiliación: Canadá